XOMA Royalty (XOMA) Cash from Investing Activities Growth (5y) (2015 - 2026)
XOMA Royalty (XOMA) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97% |
| Dec 31, 2025 | 150.55% |
| Sep 30, 2024 | 22.27% |
| Jun 30, 2024 | 24.43% |
| Mar 31, 2024 | -89.06% |
| Dec 31, 2022 | -294.45% |
| Sep 30, 2022 | 25.26% |
| Mar 31, 2022 | -52.14% |
| Dec 31, 2021 | -201.71% |
| Sep 30, 2021 | -67.68% |
| Mar 31, 2021 | -237.13% |
| Dec 31, 2020 | -15.34% |
| Sep 30, 2019 | -36.15% |
| Jun 30, 2019 | -21.08% |
| Mar 31, 2019 | -43.68% |
| Dec 31, 2017 | 14.88% |
| Sep 30, 2017 | 66.30% |
| Jun 30, 2017 | 15.59% |
| Mar 31, 2017 | 28.35% |
| Dec 31, 2016 | 49.32% |